Related Experiment Videos
Menkes kinky hair syndrome: Is it a treatable disorder?
Clinical Genetics
|February 1, 1977
Abstract:
A male infant with Menkes Kinky Hair Syndrome was treated with a 3-week course of cupric acetate infusions, which was terminated when he developed aminoaciduria. The lack of improvement seen in this infant is representative of the reported experience with parenteral copper therapy in this condition, and may be attributable to the presence of a clinically significant abnormality in copper metabolism in utero.
Insights
Parenteral copper therapy for Menkes Kinky Hair Syndrome showed no improvement in an infant, even with cupric acetate infusions. This suggests a significant in utero copper metabolism issue may limit treatment effectiveness.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Medicine
Background:
- Menkes Kinky Hair Syndrome (MKS) is a rare genetic disorder affecting copper metabolism.
- Copper is essential for various enzymatic functions, and its deficiency in MKS leads to severe neurological and connective tissue problems.
Observation:
- A male infant diagnosed with Menkes Kinky Hair Syndrome received intravenous cupric acetate infusions for three weeks.
- Treatment was discontinued prematurely due to the development of aminoaciduria, a sign of kidney dysfunction.
Findings:
- The infant showed no clinical improvement despite the copper supplementation.
- The lack of therapeutic response aligns with previous studies on parenteral copper therapy for MKS.
Implications:
- The findings suggest that copper metabolism abnormalities in MKS may be established early in fetal development.
- Parenteral copper therapy might be ineffective if the fundamental metabolic defect is severe and present before birth.
- Further research into the timing and nature of copper dysregulation in utero is warranted for MKS.